Improving responses to immunotherapy for patients with endometrial cancer

2 Mga view
administrator
administrator
09/30/23

Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, discusses a variety of possible treatment options involving immunotherapy (IO) for patients with endometrial cancer. These include IO monotherapy, IO in combination with hormone therapy, and IO in combination with chemotherapy and/or PARP inhibitors. Dr Lorusso discusses ongoing clinical trials looking into these areas and the importance of determining which patients would benefit most from which treatments. This interview took place at the European Society for Medical Oncology (ESMO) Asia congress 2022 in Singapore.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

  • Kategorya

Magpakita ng higit pa

0 Mga komento Pagbukud-bukurin Ayon

Walang nakitang komento

Mga Komento sa Facebook

Susunod